The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, M.
Right arrow Articles by Kita, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, M.
Right arrow Articles by Kita, H.
The Journal of Immunology, 2002, 169: 5252-5259.
Copyright © 2002 by The American Association of Immunologists

Platelet-Activating Factor Activates Two Distinct Effector Pathways in Human Eosinophils1

Masahiko Kato*, Hirokazu Kimura{dagger}, Youichi Motegi*, Atsushi Tachibana*, Hisanori Minakami{ddagger}, Akihiro Morikawa* and Hirohito Kita2,§

* Department of Pediatrics, Gunma University School of Medicine, and {dagger} Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi, Gunma, Japan; {ddagger} Department of Reproductive and Developmental Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan; and § Departments of Medicine and Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, MN 55905

In granulocytes, platelet-activating factor (PAF) shares many of its biological effects with other chemotactic factors, such as FMLP, complement fragments, and lipid mediators. Two unique effects are that PAF is relatively resistant to pertussis toxin (PTX) and that PAF activates the inflammatory functions of eosinophils more strongly than it activates those of neutrophils. To investigate the molecular mechanisms of the responses of eosinophils to PAF, we analyzed superoxide anion production by a chemiluminescence method that provides real-time kinetic data for the cellular responses. We found that PAF induced bimodal superoxide anion production in human eosinophils, consisting of an intense, but transient, first phase and a larger and sustained second phase. In contrast, PAF induced essentially a transient unimodal response in human neutrophils. The two phases of eosinophil response were mediated by distinct cellular mechanisms: the second phase was highly dependent on cellular adhesion and {beta}2 integrins, but the first phase was independent of both adhesion and {beta}2 integrins. The upstream signaling mechanisms were also different: the second phase was mediated by PTX-resistant G-protein(s) and through activation of phosphatidylinositol 3-kinase, while the first phase was mediated by PTX-sensitive G-protein(s). Furthermore, the second-phase response was ~100-fold more resistant to inhibition by a competitive PAF receptor antagonist than the first phase. Thus, eosinophils and neutrophils react differently to PAF, and PAF activates two separate and distinct effector pathways in human eosinophils. These two activation pathways may explain the eosinophils’ strong and diverse biological responses to PAF.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Mukai, T. Seki, H. Nakano, Y. Hokari, T. Takao, M. Kawanami, H. Tsukagoshi, H. Kimura, Y. Kiso, Y. Shimonishi, et al.
Mitocryptide-2: Purification, Identification, and Characterization of a Novel Cryptide That Activates Neutrophils
J. Immunol., April 15, 2009; 182(8): 5072 - 5080.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Korhonen, B. Fisslthaler, A. Moers, A. Wirth, D. Habermehl, T. Wieland, G. Schutz, N. Wettschureck, I. Fleming, and S. Offermanns
Anaphylactic shock depends on endothelial Gq/G11
J. Exp. Med., February 16, 2009; 206(2): 411 - 420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mukai, Y. Hokari, T. Seki, T. Takao, M. Kubota, Y. Matsuo, H. Tsukagoshi, M. Kato, H. Kimura, Y. Shimonishi, et al.
Discovery of Mitocryptide-1, a Neutrophil-activating Cryptide from Healthy Porcine Heart
J. Biol. Chem., November 7, 2008; 283(45): 30596 - 30605.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Fillon, K. Soulis, S. Rajasekaran, H. Benedict-Hamilton, J. N. Radin, C. J. Orihuela, K. C. El Kasmi, G. Murti, D. Kaushal, M. W. Gaber, et al.
Platelet-Activating Factor Receptor and Innate Immunity: Uptake of Gram-Positive Bacterial Cell Wall into Host Cells and Cell-Specific Pathophysiology
J. Immunol., November 1, 2006; 177(9): 6182 - 6191.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Inoue, Y. Matsuwaki, S.-H. Shin, J. U. Ponikau, and H. Kita
Nonpathogenic, Environmental Fungi Induce Activation and Degranulation of Human Eosinophils
J. Immunol., October 15, 2005; 175(8): 5439 - 5447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Makino, M. Glogauer, G. M. Bokoch, S. Chien, and G. W. Schmid-Schonbein
Control of neutrophil pseudopods by fluid shear: role of Rho family GTPases
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C863 - C871.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Deo, N. G. Bazan, and J. D. Hunt
Activation of Platelet-activating Factor Receptor-coupled G{alpha}q Leads to Stimulation of Src and Focal Adhesion Kinase via Two Separate Pathways in Human Umbilical Vein Endothelial Cells
J. Biol. Chem., January 30, 2004; 279(5): 3497 - 3508.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. P. L. Guarino, Z.-L. Xiao, P. Biancani, and J. Behar
PAF-like lipids- and PAF-induced gallbladder muscle contraction is mediated by different pathways in guinea pigs
Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1189 - G1197.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.